Invention Grant
- Patent Title: Peptide compound
-
Application No.: US15941030Application Date: 2018-03-30
-
Publication No.: US10435445B2Publication Date: 2019-10-08
- Inventor: Taiji Asami , Naoki Nishizawa , Ayumu Niida , Yoko Kanematsu , Mari Adachi , Shiro Takekawa , Tomoko Morimoto
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee Address: JP Osaka
- Agency: Honigman LLP
- Agent Fernando Alberdl; Jonathan P. O'Brien
- Priority: JP2017-072556 20170331
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K14/47 ; C07K14/605 ; A61K47/60 ; A61P1/08
Abstract:
The present invention provides a novel peptide compound having an activating action on GIP receptors and use of the peptide compound as a medicament.Specifically, a peptide containing a sequence represented by the formula (I) or a salt thereof and a medicament comprising the same are provided. (I) P1-Tyr-A2-Glu-Gly-Thr-A6-A7-A8-A9-A10-A11-A12-A13- A14-A15-A16-A17-A18-A19-A20-A21-A22-A23-A24-A25- A26-A27-A28-A29-A30-A31-A32-A33-A34-A35-A36-A37- A38-A39-A40-P2 wherein each symbol is as defined herein.
Public/Granted literature
- US20180298070A1 PEPTIDE COMPOUND Public/Granted day:2018-10-18
Information query
IPC分类:
